Triglyceride-glucose index for predicting repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention

Cardiovasc DiabetolPublished Cohort study

Main finding · Primary endpoint (repeat revascularization and ISR)Result — go to the resultHazard ratio 1.319 95% CI 1.063–1.637

Authors' conclusion

An increased TyG index was associated with elevated risk for long-term PCI complications, including repeat revascularization and ISR. Our study suggested that the TyG index could be a potent predictor in evaluating the prognosis of CCS patients undergoing PCI.

Study context

Population
Chronic coronary syndrome (CCS) patients undergoing percutaneous coronary intervention (PCI)
Participants
1,414 patients
Exposure
Triglyceride-glucose (TyG) index tertiles
Outcome
Composite of:
  • PCI complications
  • Including repeat revascularization
  • In-stent restenosis (ISR)
Follow-up
Median 60 months

Main finding

As reported in the abstract

Primary endpoint:
  • Repeat revascularization
  • ISR

Hazard ratio

1.319

95% CI 1.063–1.637

P = 0.012

Highest tertilevs Lowest tertile
HR 1.319 (95% CI 1.063–1.637); P = 0.012
Patients with ≥1 primary endpoint event
548 (38.76%)
TyG index (continuous), adjusted HR
1.191; 95% CI 1.038-1.367; P = 0.013
Linear dose-response relationship (restricted cubic splines (RCS))
non-linear P = 0.373, P overall = 0.035

Observational data: associations, not effects.

Original publication

Triglyceride-glucose index for predicting repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention. Cardiovasc Diabetol. Published 2 March 2023. doi:10.1186/s12933-023-01779-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.